Tag: 23andMe
January 25, 2018
What Is Genomics?
Genomics, the study of genetic information within all living beings provides an insight into a patient's genetics which opens the...
December 28, 2017
Genetics Outlook 2018: Can the Potential Show Up in the Market?
The Investing News Network takes a closer look at the genetics market in 2017 and what 2018 may have in...
July 20, 2017
Rennova Health Launches AMSG, a Machine Learning AI in the Genetic Testing Market
Rennova decided to spin off its genetic division and create a brand new, publicly traded company, INN interviews the CEO...
October 3, 2016
FDA Intervention in DTC Genetic Testing: A Timeline
There is still a great deal of debate over the FDA’s role in regulating medical devices and pharmaceutical products. So... June 16, 2016
Illumina Announces Initial Customer Orders for the Global Screening Array
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced that it has signed deals with 12 customers for its new Infinium®...
May 29, 2016
Human Genome Sciences Stock May Benefit from Big Pharma Breakthroughs
Big pharma is achieving major breakthroughs backed by genetics research, and ultimately more than one human genome sciences stock may...
December 6, 2015